Category:
Prophylactic Biological Products
CAS NO:
475207-59-1
Standard:
In-house Standards,
|
Sorafenib Tosylate with CAS 475207-59-1 is co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar.
Sorafenib Tosylate (CAS 475207-59-1) is approved in the US for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma. |
The product above are not for sales where the patents are applicable and still valid.